https://www.news-medical.net/news/20220826/New-advice-aims-to-reduce-the-cardiac-side-effects-of-cancer-treatment.aspx
Even with the above latest advice re: cardiac side effects and Dexrazoxane. Every day, Oncologists around world is struggling to make a painful decision whether to continue treatment or stop therapy that highly likely to cure cancer BUT later on kill patient with heart failure.
Hopefully Zantrene would make his job Dr Lyon easier one day.Best of both worlds as Dr Tillett said:"Enhanced anti-cancer efficacy and Cardioprotection." The holy Grail.
Ann: Appendix 4E & Annual Report, page-28
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.070(4.32%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.65 | $1.54 | $145.6K | 91.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5700 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 296 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |